Reactive oxygen species signaling in cancer: Comparison with aging

Aging and Disease

Volumn 2, Issue 3, 2011, Pages 219-230

  Afanas'ev, Igor ^a,b  

^a Vitamin Research Institute   (Russian Federation)

^b NONE   (Portugal)

Author keywords

Aging; Cancer; ROS; Signaling

Indexed keywords

EID: 84859987864     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Afanas'ev I (2009). Superoxide and nitric oxide in senescence and aging. Front Biosci, 14, (Jan.1), 3899-3912.
2. Afanas'ev I (2010). Reactive oxygen species and age-related genes p66Shc, Sirtuin, Fox03 and Klotho in senescence. Oxid Med Cell Longevity, 3, 1-9.
3. Afanas'ev I (2010). Signaling and damaging functions of free radicals in aging?free radical theory, hormesis, and TOR. Aging and Disease, 1: 75-88.
4. Saprin AN, Klochko EV, Chibrikin VM, Krugliakova KE, Emanuel' NM (1966). Kinetic regularities of changes in free radical content during malignant growth and action of inhibitors of free radical processes. Biofizika, 11: 443-52. (in Russian).
5. Afanas'ev IB (2009). Signaling Mechanisms of Oxygen and Nitrogen Free Radicals, CRC Press, Taylor & Francis Group, Boca Raton, Florida, pp. 1-205.
6. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, Bommarius B, Arnold RS, Whorton AR, Sturrock AB, Huecksteadt TP, Quinn MT, Krenitsky K, Ardie KG, Lambeth JD, Hoidal JR (2003). NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol, 285: C353-C369.
7. Kumar B, Koul S, Khandrika L, Measchan RB, Koul HK (2008). Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res, 68: 1777-85.
8. Arnold RS, He J, Remo A, Ritsick D, Yin-Goen Q, Lambeth JD, Datta MW, Young AN, Petros JA (2007). Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1. Am J Pathol, 171: 2021-32.
9. Veeramani S, Yuan TC, Lin FF, Lin MF (2008). Mitochondrial redox signaling by p66Shc in involved in regulating androgenic growth stimulation of human prostate cancer cell. Oncogene, 27: 5057-68.
10. Singh SV, Choi S, Zeng Y, Haim ER, Xiao D (2007). Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res, 67:7439-49.
11. Shukla S, Gupta S (2008). Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic Biol Med, 44:1833-45.
12. Antosiewicz J, Herman-Antociewicz A, Marynowski SW, Singh SV (2006). c-Jun NH2-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells. Cancer Res, 66: 5379-86.
13. Zhao R, Domann FE, Zhong W (2006). Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol Cancer Ther, 5: 3275-84.
14. Hong HY, Kim BC (2007). Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells. Biochem Biophys Res Commun, 362: 307-312.
15. Sun Y, St Clair DK Xu Y, Crook PA, St Clair WH (2010). A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells. Cancer Res, 70: 2880-90.
16. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS (2004). Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem, 279: 34643-54.
17. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, Oberley LW (2003). The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res, 63:1297-303.
18. Weydert C, Roling B, Liu J, Hinkhouse MM, Ritchie JM, Oberley LW, Cullen JJ (2003). Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther, 2: 361-69.
19. Teoh ML, Sun W, Smith BJ, Oberley LW, Cullen JJ (2007). Modulation of reactive oxygen species in pancreatic cancer. Clin Cancer Res, 13: 7441-50.
20. Mochizuki N, Furuta S, Mitsushita J, Shang WH, Ito M, Yokoo Y, Yamaura M, Ishizone S, Nakayagai J, Konagai A, Hirose K, Kiyosawa K, Kamata T (2006). Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene, 25: 3699-707.
21. Lee JK, Edderkaoui M, Truong P, Ohno I, Jang KT, Berti A, Pandol SJ, Gukovsaya AS (2007) NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology, 133: 1637-48.
22. Lau ST, Lin ZX, Leung PS (2010). Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappa B signaling pathweys in human pancreatic adenocarcinoma cells. Br J Cancer, 102: 583-93.
23. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, Whorton AR, Hoidal JR (2002). An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol, 282: 1212-24.
24. Govindarajan B, Sligh JE, Vincent BJ, Li M, Canter JA, NickoloffBJ, RJ Rodenburg, Smeitink JA, Oberley L, Zhang Y, Slingerland J, Arnold RS, Lambeth JD, Cohen C, Hilenski L, Griendling K, Martínez-Diez M, Cuezva JM, Arbiser JL (2007). Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J Clin Invest, 117: 719-729.
25. Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, Goto Y, Shang WH, Kubodera M, Kato M, Takata M, Saida T, Kamata T (2009). NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res, 69: 2647-2654.
26. Shono T, Yokoyama N, Uesaka T, Kuroda J, Takeya R, Yamasaki T, Amano T, Mizoguchi M, Suzuki SO, Niiro H, Miyamoto K, Akashi K, Iwaki T, Sumimoto H, Sasaki T (2008). Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. Int J Cancer, 123: 787-92.
27. Sawada M, Nakashima S, Kiyono T, Nakagawa M, Yamada J, Yamakawa H, Banno Y, Shinoda J, Nishimura Y, Nozawa Y, Sakai Y (2001). p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene, 20: 1368-78.
28. Sawada M, Kiyono T, Nakashima S, Shinoda J, Naganawa T, Hara S, Iwama T, Sakai N (2004). Molecular mechanisms of TNF-a-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and -independent pathways. Cell Death Differ, 11: 997-1008.
29. Lin CW, Yang LY, Shen SC, Shen YC (2007). IGF-I plus induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cell. J Cell Physiol, 212: 666-74.
30. Choi JA, Lee JW, Kim H, Kim EY, Seo JM, Ko J, Kim JH (2010). Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway. Carcinogenesis, 31: 543-51.
31. Cao XH, Wang AH, Wang CL, Mao DZ, Lu MF, Cui YQ, Jiao RZ (2010). Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Chem Biol Interact, 183: 357-62.
32. Deng YT, Huang HC, Lin JK (2010). Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog, 49: 141-51.
33. Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, Fabregat I (2009). Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance toTGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res, 69: 7595-602.
34. Huang J, Wu L, Tashiro S, Onodera S, Ikejima T (2008). Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. J Pharmacol Sci, 107: 370-9.
35. Chen FH, Zhang LB, Qiang L, Yang Z, Wu T, Zou MJ, Tao L, You QD, Li ZY, Yang Y, Guo QL (2010). Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG(2) cells. Cancer Lett, 296: 96-105.
36. Kim J, Adam RM, Freeman MR (2005). Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress. Cancer Res, 65: 8242-9.
37. Kim EY, Seo JM, Kim C, Lee JE, Lee KM, Kim JH (2010). BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway. Free Radic Biol Med, 49: 1072-81.
38. Park IJ, Hwang JT, Kim YM, Ha J, Park OJ (2006). Differential modulation of AMPK signaling pathways by low or high levels of exogenous reactive oxygen species in colon cancer cells. Ann N Y Acad Sci, 1091:102-9.
39. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH (2007). Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res, 67:10823-30.
40. Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, Chan KK, Ngan HY (2008). Loss of MK3 mediated by oxidative stress enhances tumorigenicity and chemiluminescence of ovarian cancer cells. Carcinogenesis, 29: 1742-50.
41. Devadas S, Zaritskaya L, Rhee SG, Oberlay L, Williams MS (2002). Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: Selective regulation of mitogen-activated protein kinase activation and Fas ligand expression. J Exp Med, 195:59-70.
42. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O, Weill B, Batteux F (2005). Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res, 65: 948-56.
43. Schumacker PT (2006). Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell, 10: 175-6.
44. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC (2005). mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA,102, 719-24.
45. Lluis JM, Buricchi F, Chiarugi P, Morales A, Fernandez-Checa JC (2007). Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-κB via c-SRC- and oxidant-dependent dell death. Cancer Res, 67: 7368-77.
46. Bensaad K, Cheung EC, Vousden KH (2009). Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J, 28: 3015-26.
47. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S, Pierron G, Codogno P (2006). NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem, 281(41): 30373-82.
48. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Codogno P (2007). Regulation of autophagy by NFkappaB transcription factor and reactive oxygen species. Autophagy, 3: 390-2.
49. Yuk JM, Shin DM, Song KS, Lim K, Kim KH, Lee SH, Kim JM, Lee JS, Paik TH, Kim JS, EK Jo (2010). Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy. Autophagy, 6: 1-15.
50. Cao J, Xu D, Wang D, Wu R, Zhang L, Zhu H, He Q, Yang B (2009). ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells. Free Radic Biol Med, 47(5): 536-47.
51. Desouki MM, Kulawiec M, Bansal S, Das GM, Singh KK (2005). Cross talk between mitochondria and superoxide generating NADPH Oxidase in breast and ovarian tumors. Cancer Biol Ther, 4: 1367-73.
52. Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermonta PJ (2009). Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci USA,106: 8683-8.
53. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Scott Budinger GR, Chandela NS (2010). Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA, 107: 8788-93.
54. Ristow M, Zarse K (2010). How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitochormesis). Exp Gerontol, 45: 410-8.
55. Droge W (2005). Oxidative aging and insulin receptor signaling. J Gerontol A Biol Sci Med Sci 1, 60: 1378-85.